Pulmonary Hypertension Association home
Pulmonary Hypertension Association
 contact us | join PHA | site map/search

PHA News Archive - August 27, 2004

vol 5, Number 18

PHA News August 27, 2004
PHA News is an e-mail newsletter from the Pulmonary Hypertension Association covering PH related topics.

PHA News editor - Sally Maddox skmaddox@bellsouth.net
reaching over 4800 subscribers

www.phassociation.org


Did You Know???

Clinical Trial information available on the PHA website at www.phassociation.org/
Clinical_Trials/

A Phase III, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Sitaxsentan Sodium (Thelin™) Treatment with an Open-label Bosentan Arm in Patients with Pulmonary Arterial Hypertension (PAH)

A Placebo-Controlled Study to Evaluate the Safety an Pilot Efficacy of Iloprost Inhalation Solution as Add-On Therapy with Bosentan in Subjects with Pulmonary Arterial Hypertension

Ambrisentan in PAH - A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study of Ambrisentan in Subjects with Pulmonary Arterial Hypertension


Topics For This Issue
Medicare project has room for more
Sales up, profits down at Bachem
Persistent Pulmonary Hypertension In The Newborn

Stopping Pulmonary Hypertension

Medicare project has room for more

Medicare demonstration project to provide coverage of some injectable medications for 50,000 beneficiaries.

Starting in September, the Medicare Replacement Drug Demonstration, mandated by the new Medicare prescription drug law, will extend drug coverage to prescription medications that can be self-administered rather than administered by a health care provider. This includes medications that are currently covered under Medicare Part B when given in a physician's office, such as drugs for the treatment of rheumatoid arthritis, multiple sclerosis, pulmonary hypertension, and a variety of cancers.

Read more...
(http://www.medicalnewstoday.com/
medicalnews.php?newsid=12511)

Sales up, profits down at Bachem
Meanwhile, there was good news for Bachem just ahead of its results when it signed an agreement to produce and supply mondoBIOTECH of Italy’s lead compound Aviptadil.

mondoBIOTECH is entering the product into a Phase II clinical trial to treat pulmonary arterial hypertension and plans to bring Aviptadil to the market in 2007.

Read Article
(http://www.inpharma.com/news/news-NG.asp?id=54198)

Learn about PH

Survival GuidePulmonary Hypertension - A Patient's Survival Guide
The premiere information resource for people dealing with PH -- THIRD edition en route from the printers to the PHA offices in Silver Spring, MD!!!

The author, a PH patient herself, knows what it is like to live with the disease. She talked to many other patients, doctors, and researchers while writing the Survival Guide. Dr. Ronald J. Oudiz and a team of physicians with a deep knowledge of PH edited the book for accuracy.

New edition contains a chart of 15 drugs used to treat PH; results of recent clinical trials; in-depth discussion of PH secondary to other diseases or conditions; a new chapter on what to eat if you have PH; and much, much more!

Persistent Pulmonary Hypertension In The Newborn

With its first breath, an infant sets changes into motion which convert the circulatory system from that of an aquatic being to that of an air breather.

Infants with persistent pulmonary hypertension are usually cyanotic with respiratory distress and tachypnea (fast respiratory rate). These infants need supplemental oxygen or, in severe cases, artificial ventilation. Diagnosis is usually confirmed by echocardiogram which will show a large right-to-left shunting of blood through the heart and/or through a patent ductus arteriosis.

Read Article
(http://asthma.about.com/library/weekly/aa051501a.htm)

Stopping Pulmonary Hypertension

NASHVILLE, Tenn. (Ivanhoe Broadcast News) -- The drug Viagra has changed the meaning of erectile dysfunction, but it may also be a lifesaving answer for some children with a serious condition known as pulmonary hypertension. For nine weeks, Tammy Russell has been here at the bedside of her 15-year-old son, Kyle. Kyle loves the beach and vacations. But like many children with Down syndrome, heart problems slow him down. This is his third time in the hospital for heart surgery.

Read Article
(http://www.healthcentral.com/news/NewsFullText.cfm?id=8009302)


Better Business Bureau Accredited Charity bbb.org/charity Charity Navigator 4 Star Charity Rating best in america seal


The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

Questions about the site? email web@PHAssociation.org

Pulmonary Hypertension Association
801 Roeder Road, Ste. 400
Silver Spring, MD 20910

Copyright © 2008 Pulmonary Hypertension Association
Read our privacy policy.

For optimal viewing of PHAssociation.org we recommend the following:

PC : Windows running Internet Explorer 5.5 or higher
Macintosh: Internet Explorer 5.2 or higher
free download from Microsoft.com

  Macromedia Flash Player
free download from Macromedia.com
  Adobe Acrobat Reader 6.0 or higher
free download from Adobe.com
Patients Medical Caregivers Media What is PH